ASCORBIC ACID

抗坏血酸

基本信息

  • 批准号:
    7598515
  • 负责人:
  • 金额:
    $ 2.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-01 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Our data suggest that the relative hypoxia in the fluids around the lens is important to protect the lens against the most common type of age-related cataract. Destruction of the vitreous gel leads to increased exposure of the lens to oxygen and the formation of nuclear cataracts. We detected oxygen gradients in the eyes of patients undergoing retinal surgery that predicted that the vitreous body must be consuming oxygen. Direct tests of oxygen consumption in isolated vitreous humor confirmed this predication and demonstrated that this effect was independent of cellular metabolic activity and dependent on ascorbate. Previous studies in rabbits have suggested that ascorbate enters the eye in the aqueous humor that nourishes the structures of the anterior of the eye (ascorbate concentrations in aqueous humor are >20X greater than in the blood). It was believed that ascorbate in the posterior of the eye was derived by diffusion from the aqueous humor. However, unlike other species, humans have higher ascorbate in the vitreous humor (in the posterior of the eye) than in the (anterior) aqueous humor, ruling out the aqueous as the sole source of ascorbate for the human vitreous. To get a better idea of the ascorbate distribution in the eye and, therefore, the sources and sinks for ascorbate, we would like to measure ascorbate gradients in the eyes of living rabbits and humans.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID BEEBE其他文献

DAVID BEEBE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID BEEBE', 18)}}的其他基金

RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT NO 2375 - MASSIVELY PARALLEL CENTRALIZED AND DECENTRALIZED ULTRAFAST COVID-19INFECTIOUS
快速加速诊断 (RADX) 计划:技术项目编号 2375 - 大规模并行集中式和分散式超快 COVID-19 感染
  • 批准号:
    10506003
  • 财政年份:
    2020
  • 资助金额:
    $ 2.34万
  • 项目类别:
ASCORBATE METABOLOME IN THE VITREOUS AND AQUEOUS HUMOR OF THE EYE
眼睛玻璃体和房水中的抗坏血酸代谢组
  • 批准号:
    7721559
  • 财政年份:
    2008
  • 资助金额:
    $ 2.34万
  • 项目类别:
ASCORBIC ACID
抗坏血酸
  • 批准号:
    7721109
  • 财政年份:
    2007
  • 资助金额:
    $ 2.34万
  • 项目类别:
ASCORBIC ACID
抗坏血酸
  • 批准号:
    7357365
  • 财政年份:
    2005
  • 资助金额:
    $ 2.34万
  • 项目类别:

相似海外基金

The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
  • 批准号:
    10667863
  • 财政年份:
    2023
  • 资助金额:
    $ 2.34万
  • 项目类别:
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
房水液体活检对视网膜母细胞瘤儿童分子预测和监测的验证。
  • 批准号:
    10718932
  • 财政年份:
    2023
  • 资助金额:
    $ 2.34万
  • 项目类别:
Regulation of aqueous humor flow by exosomal miRNA
外泌体 miRNA 对房水流动的调节
  • 批准号:
    23K09011
  • 财政年份:
    2023
  • 资助金额:
    $ 2.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of experimental basis to improve the prognosis of corneal transplantation in treating bullous keratoplasty due to pathological aqueous humor.
为改善角膜移植治疗病理性房水所致大疱性角膜移植术的预后奠定实验基础。
  • 批准号:
    23H03063
  • 财政年份:
    2023
  • 资助金额:
    $ 2.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma
用工程纳米颗粒调节房水流出以治疗青光眼
  • 批准号:
    10649763
  • 财政年份:
    2023
  • 资助金额:
    $ 2.34万
  • 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
  • 批准号:
    10510279
  • 财政年份:
    2022
  • 资助金额:
    $ 2.34万
  • 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
  • 批准号:
    10682543
  • 财政年份:
    2022
  • 资助金额:
    $ 2.34万
  • 项目类别:
ocular tissue response by intraocular pressure and aqueous humor in glaucoma - investigation for the mechanism and biomarkers of intraocular pressure regulation
青光眼中眼压和房水引起的眼组织反应——眼压调节机制和生物标志物的研究
  • 批准号:
    20H03839
  • 财政年份:
    2020
  • 资助金额:
    $ 2.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
  • 批准号:
    10155489
  • 财政年份:
    2020
  • 资助金额:
    $ 2.34万
  • 项目类别:
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
  • 批准号:
    10405079
  • 财政年份:
    2020
  • 资助金额:
    $ 2.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了